Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Pleomorphic liposarcoma.

A M Oliveira1, A G Nascimento

  • 1Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN 55905, USA.

Seminars in Diagnostic Pathology
|January 5, 2002
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Cytogenetic and pollen analysis in Passiflora triloba (Passifloraceae).

Brazilian journal of biology = Revista brasleira de biologia·2025
Same author

Arteritis, aneurysm and thromboembolic colic caused by migration of Strongylus vulgaris larvae in equids.

Journal of equine veterinary science·2025
Same author

Efficacy and safety of office-based procedures for hemorrhoidal disease in patients with inflammatory bowel disease.

Techniques in coloproctology·2025
Same author

Corrigendum to "SELNET clinical practice guidelines for soft tissue sarcoma and GIST" [Cancer Treat. Rev. 102 (2021) 102312].

Cancer treatment reviews·2023
Same author

Cutaneous phaeohyphomycosis in a greater bulldog bat (Noctilio leporinus) in northeastern Brazil.

Journal of comparative pathology·2023
Same author

Corrigendum to "SELNET clinical practice guidelines for bone sarcoma" Critical reviews in oncology/hematology, vol. 174 (2022), 1-10.

Critical reviews in oncology/hematology·2022
Same journal

Update on the molecular pathology of the distinctive giant cell, fibro-osseous and bone forming lesions of the jaws.

Seminars in diagnostic pathology·2026
Same journal

Update on the molecular pathology and classification of odontogenic cysts and tumours.

Seminars in diagnostic pathology·2026
Same journal

MDM2 gene amplification in surgical pathology: biology, diagnostic utility, and clinical relevance in the modern era.

Seminars in diagnostic pathology·2026
Same journal

When three negatives equal a positive: Molecular updates of triple-negative breast carcinomas with favorable prognoses.

Seminars in diagnostic pathology·2026
Same journal

Old school, new insight: Revisiting histomorphology in the modern era of prostate cancer risk stratification.

Seminars in diagnostic pathology·2026
Same journal

Recent advances in genetic predisposition to primary testicular tumors.

Seminars in diagnostic pathology·2026
See all related articles

Pleomorphic liposarcoma (PLS), a high-grade sarcoma, frequently affects older individuals in the extremities. Tumors larger than 10 cm or in the upper extremities are linked to poorer survival outcomes.

Area of Science:

  • Oncology
  • Surgical Pathology
  • Sarcoma Research

Background:

  • Pleomorphic liposarcoma (PLS) is a high-grade pleomorphic sarcoma characterized by multivacuolated lipoblasts.
  • This rare sarcoma most commonly affects the extremities of older adults and has a propensity for lung metastasis.

Purpose of the Study:

  • To analyze clinicopathologic features and survival outcomes of pleomorphic liposarcoma (PLS) in the extremities.
  • To identify prognostic factors associated with overall survival in PLS patients.

Main Methods:

  • A retrospective analysis combining data from 16 previously reported cases and 8 new cases of PLS.
  • Univariate analysis was performed to assess the association between clinicopathologic variables and overall survival.

Related Experiment Videos

Main Results:

  • The 5-year overall survival rate for 24 PLS patients was 40% (median survival, 48 months).
  • Tumor location in the upper extremities (P = .021) and size greater than 10 cm (P = .047) were significantly associated with decreased overall survival.
  • Older age, female sex, epithelioid phenotype, and adjuvant therapy did not significantly impact survival.

Conclusions:

  • Pleomorphic liposarcoma (PLS) of the extremities has a guarded prognosis, with a 5-year survival rate of 40%.
  • Tumor size and location are significant prognostic indicators for PLS.
  • Further research is needed to explore therapeutic strategies for improving PLS outcomes.